Nonprofits›Reboot Rx Inc

Medical Research

Reboot Rx Inc

WINCHESTER, MA

Website

Total revenue

$2.7M

Total expenses

$975K

Net assets

$2.5M

Grants received

$3.5M

19 grants

EIN

844384737

Tax year

2023

Mission

Reboot Rx is transforming cancer care by using proprietary AI technology to repurpose generic drugs into affordable and effective treatments.

Financials

FY 2023

Revenue

Contributions & grants$2.7M
Program service revenue—
Investment income$35K
Other revenue—
Total revenue$2.7M

Expenses

Grants paid—
Salaries & benefits$805K
Fundraising$58K
Other expenses$170K
Total expenses$975K
Total assets$2.6M
Net assets$2.5M

People

8 listed

NameRoleCompensation

Laura Kleiman

President CEO and Director

Board

$154K

40 hrs/wk

Pradeep Mangalath

Director

Board

—

2 hrs/wk

Lara Metcalf

Director

Board

—

2 hrs/wk

Robert Pozen

Director

Board

—

2 hrs/wk

Mason Irving III

Director

Board

—

2 hrs/wk

Andrea Pollinger

Board Chair and Clerk

Board

—

2 hrs/wk

David Noymer

Treasurer

Board

—

2 hrs/wk

Sherif Botros

Head of Data Science

Staff

$153K

40 hrs/wk

Grants received

Showing 19 of 19

FromAmountPurposeYear
LAURA AND JOHN ARNOLD FOUNDATION
$500K
TO (1) RESEARCH AND EXPLORE POLICIES THAT WOULD ENABLE THE FDA TO INCORPORATE UPDATED INFORMATION ON A REPURPOSED GENERIC DRUG'S LABEL AND (2) CREATE PAYER-DIRECTED MATERIALS THAT COMMUNICATE THE IMPACT AND VALUE OF A REPURPOSED GENERIC DRUG.
2024
LAURA AND JOHN ARNOLD FOUNDATION
$221K
TO RESEARCH STAKEHOLDERS THAT INFLUENCE WHETHER REPURPOSED GENERIC DRUGS ARE ULTIMATELY PRESCRIBED FOR CANCER PATIENTS, AND TO DEVELOP A STRATEGY FOR DRIVING ADOPTION OF NEW REPURPOSED GENERIC DRUGS INTO THE STANDARD OF CARE.
2024
DRAPER RICHARDS KAPLAN FOUNDATION
$100K
GENERAL OPERATING SUPPORT
2024
PROGRESS FOR INFORMATICS & ENERGY
$65K
HEALTH RESEARCH
2024
FFWD
$38K
General Support
2024
LAURA AND JOHN ARNOLD FOUNDATION
$279K
TO RESEARCH STAKEHOLDERS THAT INFLUENCE WHETHER REPURPOSED GENERIC DRUGS ARE ULTIMATELY PRESCRIBED FOR CANCER PATIENTS, AND TO DEVELOP A STRATEGY FOR DRIVING ADOPTION OF NEW REPURPOSED GENERIC DRUGS INTO THE STANDARD OF CARE.
2023
DRAPER RICHARDS KAPLAN FOUNDATION
$100K
GENERAL OPERATING SUPPORT
2023
BROTHERS BROOK FOUNDATION
$50K
CURE OR TREATMENT FOR CHRONIC DISEASE
2023
PROGRESS FOR INFORMATICS & ENERGY
$50K
HEALTH RESEARCH
2023
FIDELITY INVESTMENTS CHARITABLE GIFT FUND
$16K
For grant recipient's exempt purposes
2023
DRAPER RICHARDS KAPLAN FOUNDATION
$50K
GENERAL OPERATING SUPPORT
2022
BROTHERS BROOK FOUNDATION
$50K
TREATMENT/CURE FOR CHRONIC DISEASE
2022
FIDELITY INVESTMENTS CHARITABLE GIFT FUND
$6K
For grant recipient's exempt purposes
2022
FIDELITY INVESTMENTS CHARITABLE GIFT FUND
$257K
For grant recipient's exempt purposes
2021
FIDELITY INVESTMENTS CHARITABLE GIFT FUND
$257K
For grant recipient's exempt purposes
2021
Radhika & Ambarish Malpani Foundation Inc
$10K
General & Unrestricted
2021
FFWD
$70K
General Support
2020
FIDELITY INVESTMENTS CHARITABLE GIFT FUND
$11K
For grant recipient's exempt purposes
2020
Partnership for Cures
$1.4M
CANCER AI RESEARCH
2019

Funded by

$3.5M from 8 funders · 19 grants · 2019–2024

Partnership for Cures

$1.4M · 1 grant · 2019

Laura And John Arnold Foundation

$1.0M · 3 grants · 2023–2024

Fidelity Investments Charitable Gift Fund

$545K · 5 grants · 2020–2023

Draper Richards Kaplan Foundation

$250K · 3 grants · 2022–2024

Progress For Informatics & Energy

$115K · 2 grants · 2023–2024

Ffwd

$107K · 2 grants · 2020–2024

Brothers Brook Foundation

$100K · 2 grants · 2022–2023

Details

EIN844384737
NTEE codeH30
Subsection03
Ruling date2020-05
Formed2020
Employees17
REBOOT RX INC — Mission, Financials & Grants Received | Grantivo